Annual CAPEX
$2.26 M
+$1.74 M+331.87%
31 December 2023
Summary:
Xeris Biopharma Holdings annual capital expenditures is currently $2.26 million, with the most recent change of +$1.74 million (+331.87%) on 31 December 2023. During the last 3 years, it has risen by +$1.89 million (+500.27%). XERS annual CAPEX is now at all-time high.XERS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$87.00 K
-$310.00 K-78.09%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly capital expenditures is currently $87.00 thousand, with the most recent change of -$310.00 thousand (-78.09%) on 30 September 2024. Over the past year, it has dropped by -$258.00 thousand (-74.78%). XERS quarterly CAPEX is now -94.38% below its all-time high of $1.55 million, reached on 30 June 2023.XERS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$780.00 K
-$258.00 K-24.86%
30 September 2024
Summary:
Xeris Biopharma Holdings TTM capital expenditures is currently $780.00 thousand, with the most recent change of -$258.00 thousand (-24.86%) on 30 September 2024. Over the past year, it has dropped by -$1.48 million (-65.53%). XERS TTM CAPEX is now -65.53% below its all-time high of $2.26 million, reached on 30 September 2023.XERS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +331.9% | -74.8% | -65.5% |
| 3 y3 years | +500.3% | -71.7% | -33.8% |
| 5 y5 years | +49.9% | -76.4% | -29.9% |
XERS CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +500.3% | -94.4% | at low | -65.5% | +49.1% |
| 5 y | 5 years | at high | +500.3% | -94.4% | +535.0% | -65.5% | +106.9% |
| alltime | all time | at high | +6365.7% | -94.4% | +535.0% | -65.5% | +128.1% |
Xeris Biopharma Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $87.00 K(-78.1%) | $780.00 K(-24.9%) |
| June 2024 | - | $397.00 K(+142.1%) | $1.04 M(-52.6%) |
| Mar 2024 | - | $164.00 K(+24.2%) | $2.19 M(-3.3%) |
| Dec 2023 | $2.26 M(+331.9%) | $132.00 K(-61.7%) | $2.26 M(0.0%) |
| Sept 2023 | - | $345.00 K(-77.7%) | $2.26 M(+8.1%) |
| June 2023 | - | $1.55 M(+550.4%) | $2.09 M(+174.8%) |
| Mar 2023 | - | $238.00 K(+80.3%) | $762.00 K(+45.4%) |
| Dec 2022 | $524.00 K(-51.7%) | $132.00 K(-25.0%) | $524.00 K(+0.2%) |
| Sept 2022 | - | $176.00 K(-18.5%) | $523.00 K(-20.0%) |
| June 2022 | - | $216.00 K(+64.9%) | $654.00 K(-39.7%) |
| Dec 2021 | $1.08 M(+187.8%) | $131.00 K(-57.3%) | $1.08 M(-8.0%) |
| Sept 2021 | - | $307.00 K(+40.8%) | $1.18 M(+38.4%) |
| June 2021 | - | $218.00 K(-49.2%) | $852.00 K(+9.2%) |
| Mar 2021 | - | $429.00 K(+90.7%) | $780.00 K(+106.9%) |
| Dec 2020 | $377.00 K | $225.00 K(-1225.0%) | $377.00 K(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$20.00 K(-113.7%) | $396.00 K(-49.6%) |
| June 2020 | - | $146.00 K(+461.5%) | $785.00 K(-15.9%) |
| Mar 2020 | - | $26.00 K(-89.3%) | $933.00 K(-15.7%) |
| Dec 2019 | $1.11 M(-26.7%) | $244.00 K(-33.9%) | $1.11 M(-0.5%) |
| Sept 2019 | - | $369.00 K(+25.5%) | $1.11 M(-26.5%) |
| June 2019 | - | $294.00 K(+47.0%) | $1.51 M(+10.0%) |
| Mar 2019 | - | $200.00 K(-20.0%) | $1.38 M(-8.8%) |
| Dec 2018 | $1.51 M(+115.7%) | $250.00 K(-67.6%) | $1.51 M(+0.9%) |
| Sept 2018 | - | $771.00 K(+394.2%) | $1.50 M(+99.5%) |
| June 2018 | - | $156.00 K(-53.2%) | $750.00 K(+8.5%) |
| Mar 2018 | - | $333.00 K(+41.1%) | $691.00 K(-1.3%) |
| Dec 2017 | $700.00 K(+1900.0%) | $236.00 K(+844.0%) | $700.00 K(+50.9%) |
| Sept 2017 | - | $25.00 K(-74.2%) | $464.00 K(+5.7%) |
| June 2017 | - | $97.00 K(-71.6%) | $439.00 K(+28.4%) |
| Mar 2017 | - | $342.00 K | $342.00 K |
| Dec 2016 | $35.00 K | - | - |
FAQ
- What is Xeris Biopharma Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual CAPEX year-on-year change?
- What is Xeris Biopharma Holdings quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly CAPEX year-on-year change?
- What is Xeris Biopharma Holdings TTM capital expenditures?
- What is the all time high TTM CAPEX for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM CAPEX year-on-year change?
What is Xeris Biopharma Holdings annual capital expenditures?
The current annual CAPEX of XERS is $2.26 M
What is the all time high annual CAPEX for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual capital expenditures is $2.26 M
What is Xeris Biopharma Holdings annual CAPEX year-on-year change?
Over the past year, XERS annual capital expenditures has changed by +$1.74 M (+331.87%)
What is Xeris Biopharma Holdings quarterly capital expenditures?
The current quarterly CAPEX of XERS is $87.00 K
What is the all time high quarterly CAPEX for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly capital expenditures is $1.55 M
What is Xeris Biopharma Holdings quarterly CAPEX year-on-year change?
Over the past year, XERS quarterly capital expenditures has changed by -$258.00 K (-74.78%)
What is Xeris Biopharma Holdings TTM capital expenditures?
The current TTM CAPEX of XERS is $780.00 K
What is the all time high TTM CAPEX for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM capital expenditures is $2.26 M
What is Xeris Biopharma Holdings TTM CAPEX year-on-year change?
Over the past year, XERS TTM capital expenditures has changed by -$1.48 M (-65.53%)